MyFinsight
Home
Blog
About
Contact
nmtc: the income statement
Download
Download image
Net loss
-$3,605,374
(70.73%↑ Y/Y)
Product gross profit
$5,141,406
Cost of product
revenue
$3,956,286
Loss before income
taxes
-$3,605,374
(70.73%↑ Y/Y)
Other income, net
$170,492
Fair value change in
warrant liability
-$784,670
(-339.89%↓ Y/Y)
Product revenue
$9,097,692
(163.47%↑ Y/Y)
Financing costs
$334,063
(45.89%↑ Y/Y)
Loss from operations
-$4,226,473
(64.45%↑ Y/Y)
Collaborations revenue
$3,000,000
Product gross profit
$5,141,406
(376.20%↑ Y/Y)
Cost of product
revenue
$3,956,286
(66.70%↑ Y/Y)
Total operating
expenses
$12,367,879
(-4.62%↓ Y/Y)
Research and development
$4,983,362
(-1.62%↓ Y/Y)
Selling, general and
administrative
$7,384,517
(-6.55%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)